Skip to main content
Log in

Cross-reaction of antibody against Helicobacter pylori urease B with platelet glycoprotein IIIa and its significance in the pathogenesis of immune thrombocytopenic purpura

  • Original Article
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

Many clinical investigations have suggested that Helicobacter pylori (H. pylori) infection might be associated with immune thrombocytopenic purpura (ITP), but its role in the pathogenesis of ITP is unsettled. In this study, we cultured H. pylori, produced recombinant H. pylori urease (ure) B, and then prepared monoclonal antibody (MoAb) against ureB, 1F11, both 1F11 and MoAb against human platelet glycoprotein (GP) IIIa, SZ21, could bind to the band of GP IIIa of normal platelet lysate, but not to that from a patient with Glanzmann thrombasthenia (GT) whose GP IIb–IIIa complex was absent. Flow cytometry showed that normal platelets were reacted with 1F11 and SZ21, while GT platelets were not. In immuno-radiometric assay, the binding of 125I-labeled 1F11 to GP IIIa was higher than that to GP Ib, GP IIb, GP VI, and P-selectin. 1F11 could partly compete with SZ21 in a binding to platelet surface. In addition, 1F11 inhibited platelet aggregation induced by adenosine diphosphate, but had no effect on platelet P-selectin expression or Thromboxane B2 production of platelets. These results indicate that H. pylori ureB antibody could cross-react with human platelet GP IIIa and partly inhibit platelet aggregation. UreB may be a crucial component of H. pylori involved in the pathogenesis of a subset of ITP.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9

Similar content being viewed by others

References

  1. Marshall BJ, Warren RM. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984;16:1311–5. doi:10.1016/S0140-6736(84)91816-6.

    Article  Google Scholar 

  2. Ishikawa N, Fuchigami T, Matsumoto T, Kobayashi H, Sakai Y, Tabata H, et al. Helicobacter pylori infection in rheumatoid arthritis: effect of drugs on prevalence and correlation with gastroduodenal lesions. Rheumatology. 2002;41:72–7. doi:10.1093/rheumatology/41.1.72.

    Article  CAS  PubMed  Google Scholar 

  3. De Vita S, Ferraccioli G, Avellini C, Sorrentino D, Dolcetti R, Di Loreto C, et al. Widespread clonal B-cell disorder in Sjogren’s syndrome predisposing to Helicobacter pylori-related gastric lymphoma. Gastroenterology. 1996;110:1969–74. doi:10.1053/gast.1996.v110.pm8964425.

    Article  PubMed  Google Scholar 

  4. Sawalha AH, Schmid WR, Binder SR, Bacino DK, Harley JB. Association between systemic lupus erythematosus and Helicobacter pylori seronegativity. J Rheumatol. 2004;31:1546–50.

    PubMed  Google Scholar 

  5. Hershko C, Ianculovich M, Souroujon M. A hematologist’s view of unexplained iron deficiency anemia in males: impact of Helicobacter pylori eradication. Blood Cells Mol Dis. 2007;38:45–53. doi:10.1016/j.bcmd.2006.09.006.

    Article  CAS  PubMed  Google Scholar 

  6. Blaser MJ, Atherton JC. Helicobacter pylori persistence: biology and disease. J Clin Invest. 2004;113:321–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Gasbarrini A, Franceschi F, Tartaglione R, Landolfi R, Pola P, Gasbarrini G. Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori. Lancet. 1998;352:878. doi:10.1016/S0140-6736(05)60004-9.

    Article  CAS  PubMed  Google Scholar 

  8. Franchini M. Thrombotic thrombocytopenic purpura: proposal of a new pathogenic mechanism involving Helicobacter pylori infection. Med Hypotheses. 2005;65:1128–31. doi:10.1016/j.mehy.2005.06.015.

    Article  CAS  PubMed  Google Scholar 

  9. Veneri D, Krampera M, Franchini M. High prevalence of sustained remission of idiopathic thrombocytopenic purpura after Helicobacter pylori eradication: a long-term follow-up study. Platelets. 2005;16:117–9. doi:10.1080/09537100400015153.

    Article  CAS  PubMed  Google Scholar 

  10. Kodama M, Kitadai Y, Ito M, Kai H, Masuda H, Tanaka S, et al. Immune response to CagA protein is associated with improved platelet count after Helicobacter pylori eradication in patients with idiopathic thrombocytopenic purpura. Helicobacter. 2007;12:36–42. doi:10.1111/j.1523-5378.2007.00477.x.

    Article  CAS  PubMed  Google Scholar 

  11. Asahi A, Kuwana M, Suzuki H, Hibi T, Kawakami Y, Ikeda Y. Effects of a Helicobacter pylori eradication regimen on anti-platelet autoantibody response in infected and uninfected patients with idiopathic thrombocytopenic purpura. Haematologica. 2006;91:1436–7.

    CAS  PubMed  Google Scholar 

  12. Michel M, Cooper N, Jean C, Frissora C, Bussel JB. Does Helicobater pylori initiate or perpetuate immune thrombocytopenic purpura? Blood. 2004;103:890–6. doi:10.1182/blood-2003-03-0900.

    Article  CAS  PubMed  Google Scholar 

  13. Jarque I, Andreu R, Llopis I, De la Rubia J, Gomis F, Senent L, et al. Absence of platelet response after eradication of Helicobacter pylori infection in patients with chronic idiopathic thrombocytopenic purpura. Br J Haematol. 2001;115:1002–3. doi:10.1046/j.1365-2141.2001.03194.x.

    Article  CAS  PubMed  Google Scholar 

  14. Arents NL, van Zwet AA, Thijs JC, Kooistra-Smid AM, van Slochteren KR, Degener JE, et al. The importance of vacA, cagA, and iceA genotypes of Helicobacter pylori infection in peptic ulcer disease and gastroesophageal reflux disease. Am J Gastroenterol. 2001;96:2603–8. doi:10.1111/j.1572-0241.2001.04104.x.

    Article  CAS  PubMed  Google Scholar 

  15. Hovey JG, Watson EL, Langford ML, Hildebrandt E, Bathala S, Bolland JR, et al. Genetic microheterogeneity and phenotypic variation of Helicobacter pylori arginase in clinical isolates. BMC Microbiol. 2007;7:26–40. doi:10.1186/1471-2180-7-26.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Fan X, Gunasena H, Cheng Z, Espejo R, Crowe SE, Ernst PB, et al. Helicobacter pylori urease binds to class II MHC on gastric epithelial cells and induces their apoptosis. J Immunol. 2000;165:1918–24.

    Article  CAS  PubMed  Google Scholar 

  17. Yamanishi S, Iizumi T, Watanabe E, Shimizu M, Kamiya S, Nagata K, et al. Implications for induction of autoimmunity via activation of B-1 cells by Helicobacter pylori urease. Infect Immun. 2006;74:248–56. doi:10.1128/IAI.74.1.248-256.2006.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Iizumi T, Yamanishi S, Kumagai Y, Nagata K, Kamiya S, Hirota K, et al. Augmentation of Helicobacter pylori urease activity by its specific IgG antibody: implications for bacterial colonization enhancement. Biomed Res. 2005;26:35–42. doi:10.2220/biomedres.26.35.

    Article  CAS  PubMed  Google Scholar 

  19. Ruan G, Du XP, Xi XD, Castaldi PA, Berndt MC. A murine antiglycoprotein Ib complex monoclonal antibody, SZ 2, inhibits platelet aggregation induced by both ristocetin and collagen. Blood. 1987;69:570–7.

    CAS  PubMed  Google Scholar 

  20. Zhao Y, He Y, Shen W, Ruan C. Plasma P-selectin measurement using immunoassay method and its clinical significance. J Exp Hematol. 1997;5:426–8.

    Google Scholar 

  21. Bohr UR, Annibale B, Franceschi F, Roccarina D, Gasbarrini A. Extragastric manifestations of Helicobacter pylori infection—other Helicobacters. Helicobacter. 2007;12:S45–53. doi:10.1111/j.1523-5378.2007.00533.x.

    Article  Google Scholar 

  22. Takahashi T, Yujiri T, Shinohara K, Inoue Y, Sato Y, Fujii Y, et al. Molecular mimicry by Helicobacter pylori CagA protein may be involved in the pathogenesis of H. pylori-associated chronic immune thrombocytopenic purpura. Br J Haematol. 2004;124:91–6. doi:10.1046/j.1365-2141.2003.04735.x.

    Article  CAS  PubMed  Google Scholar 

  23. Franceschi F, Christodoulides N, Kroll MH, Genta RM. Helicobacter pylori and idiopathic thrombocytopenic purpura. Ann Intern Med. 2004;140:766–7.

    Article  PubMed  Google Scholar 

  24. Perez-Perez GL, Bhat N, Gaensbauer L, Fraser A, Taylor DN, Kuipers EL, et al. Country specific constancy by age in Cag+ proportion of Helicobacter pylori infection. Int J Cancer. 1997;72:453–6. doi:10.1002/(SICI)1097-0215(19970729)72:3<453::AID-IJC13>3.0.CO;2-D.

    Article  CAS  PubMed  Google Scholar 

  25. Moot DT, Mobley HL, Chippendale GR, Lewison JF, Resau JH. Helicobacter pylori urease activity is toxic to human gastric epithelial cells. Infect Immun. 1990;58:1992–4.

    Google Scholar 

  26. Malmsten C, Kindahl H, Samulsson B, Levy-Toledano S, Tobelem G, Caen JP. Thromboxane synthesis and the platelet release reaction in Bernard-Soulier syndrome, thrombasthenia Glanzmann and Hermansky-Pudlak syndrome. Br J Haematol. 1977;35:511–20. doi:10.1111/j.1365-2141.1977.tb00617.x.

    Article  CAS  PubMed  Google Scholar 

  27. Wucherpfennig KW. Mechanisms for the induction of autoimmunity by infectious agents. J Clin Invest. 2001;108:1091–104.

    Article  Google Scholar 

Download references

Acknowledgments

This work was supported by a grant from the Natural Science Foundation of China (30770917).

Conflict of interest statement

The authors have declared that no conflict of interest exists.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Zhaoyue Wang.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material, approximately 228 KB.

About this article

Cite this article

Bai, Y., Wang, Z., Bai, X. et al. Cross-reaction of antibody against Helicobacter pylori urease B with platelet glycoprotein IIIa and its significance in the pathogenesis of immune thrombocytopenic purpura. Int J Hematol 89, 142–149 (2009). https://doi.org/10.1007/s12185-008-0247-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12185-008-0247-4

Keywords

Navigation